HRT Financial’s ProKidney PROK Stock Holding History

HRT Financial’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$212K	Buy	+118,981	New	+$252K	﹤0.01%	3161
2025 Q4	–	Sell	-211,326	Closed	-$511K	–	3851
2025 Q3	$511K	Sell	211,326 -4,044	-2%	-$10.8K	﹤0.01%	1884
2025 Q2	$127K	Buy	+215,370	New	+$168K	﹤0.01%	2162
2024 Q2	–	Sell	-171,697	Closed	-$281K	–	2918
2024 Q1	$281K	Buy	+171,697	New	+$252K	﹤0.01%	1596
2023 Q2	–	Sell	-64,507	Closed	-$730K	–	3101
2023 Q1	$730K	Buy	+64,507	New	+$687K	0.01%	1129
2022 Q3	–	Sell	-156,274	Closed	-$1.55M	–	3340
2022 Q2	$1.55M	Buy	156,274 +4,985	+3%	+$49.3K	0.02%	682
2022 Q1	$1.49M	Buy	151,289 +76,478	+102%	+$754K	0.01%	787
2021 Q4	$740K	Hold	74,811	–	–	﹤0.01%	1439
2021 Q3	$733K	Buy	74,811 +27,298	+57%	+$269K	﹤0.01%	1668
2021 Q2	$481K	Buy	+47,513	New	+$480K	﹤0.01%	1820

Other funds holding PROK

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AGP

Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

HRT Financial's PROK Position: Q1 2026 in Review

HRT Financial opened a new position in ProKidney (PROK) in Q1 2026: 118,981 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #3161 among its holdings. This is a return to the name: HRT Financial previously reported a position in PROK as recently as Q3 2025.

HRT Financial first reported a position in PROK in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.55M in Q2 2022. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

HRT Financial held 118,981 shares of ProKidney worth $212K as of Q1 2026.
ProKidney was a new HRT Financial position in Q1 2026.
ProKidney made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3161 holding.
HRT Financial first reported a position in ProKidney in Q2 2021 and has held it in 10 quarters since.
HRT Financial's ProKidney position peaked at $1.55M in Q2 2022.
71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.